New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 29, 2013
12:12 EDTFIATY, BP, XOM, GM, CVX, F, RDS.AEPA proposes achievable cleaner fuels and cars standard
In a press release, the U.S. Environmental Protection Agency, EPA, proposed sensible standards for cars and gasoline that will significantly reduce harmful pollution, prevent thousands of premature deaths and illnesses, while also enabling efficiency improvements in the cars and trucks we drive.The proposal will enable the greatest pollution reductions at the lowest cost. The proposal will slash emissions of a range of harmful pollutants that can cause premature death and respiratory illnesses, including reducing smog-forming volatile organic compounds and nitrogen oxides by 80 percent, establish a 70 percent tighter particulate matter standard, and reduce fuel vapor emissions to near zero. The proposal will also reduce vehicle emissions of toxic air pollutants, such as benzene and 1,3-butadiene, by up to 40 percent.The proposed sulfur standards will cost refineries less than a penny per gallon of gasoline on average once the standards are fully in place. The proposed vehicle standards will have an average cost of about $130 per vehicle in 2025. The proposal also includes flexibilities for small businesses, including hardship provisions and additional lead time for compliance. Reference Link
News For A;CVX;BP;F;GM;FIATY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
May 19, 2015
07:08 EDTGMGeneral Motors sees maintaining profitability goals in China, WSJ reports
Subscribe for More Information
May 18, 2015
19:12 EDTAOn The Fly: After Hours Movers
Subscribe for More Information
17:15 EDTAAgilent down almost 5% after Q2 earnings results, guidance
16:10 EDTAAgilent sees FY15 EPS $1.67- $1.73, consensus $1.69
Subscribe for More Information
16:07 EDTAAgilent sees Q3 EPS 38c-42c, consensus 42c
Sees Q3 revenue $995M-$1.015B, consensus $1B.
16:06 EDTAAgilent reports Q2 EPS 38c, consensus 39c
Subscribe for More Information
15:00 EDTANotable companies reporting after market close
Subscribe for More Information
12:33 EDTFMarathon Patent unit enters into settlement agreement with Jaguar Land Rover
Subscribe for More Information
10:01 EDTCVX, BPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:54 EDTF, GMNHTSA looks to accelerate V2V rollout by automakers, Motor Authority says
Automakers have been notified that initial proposals for the implementation of vehicle-to-vehicle technology will be outlined by before January 1, 2016, which would be a full year ahead of schedule, according to Motor Authority. Publicly traded automakers include Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VLKAY). Mobileye (MBLY) makes chips utilized in advanced driver assistance systems. Reference Link
09:36 EDTCVXActive equity options trading on open
Subscribe for More Information
09:20 EDTCVXW.R. Grace, Chevron JV to build catalysts plant in Lake Charles, LA
Subscribe for More Information
08:12 EDTBPBP downgraded to Sell from Neutral at Goldman
Goldman downgraded BP to Sell based on limited upstream growth, a slowdown in asset disposals, and ongoing overhang from Macondo.
07:56 EDTCVXKosmos provides update on Mauritania drilling
Subscribe for More Information
07:23 EDTCVXChevron downgraded to Sell from Neutral at Goldman
Subscribe for More Information
06:26 EDTF, GMStudy shows Toyota and Honda leads in best supplier relations, Reuters says
A new study revealed that Toyota (TM) and Honda (HMC) led automakers with U.S. plants in supplier relations, reports Reuters. According to the study led by Planning Perspectives President John Henke, Toyota led Honda while Ford (F) was a distant third and Nissan (NSANY) came in fourth. General Motors (GM) and Fiat Chrysler (FCAU) were last on the list. Reference Link
May 15, 2015
16:51 EDTGMGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
16:28 EDTGMAppaloosa Management gives quarterly update on stakes
Subscribe for More Information
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
06:44 EDTBP, CVXEnvironmentalists file lawsuit over oil train safety rules, NY Times says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use